It is known that post-transplantation erythrocytosis is associated with ADPKD, with several mechanisms contributing to the development of the post-transplantation erythrocytosis, including increased erythropoietin production and activation of the renin angiotensin system due to renal structural changes [7, 8]. This evidence concerns the gene EPO and autosomal dominant polycystic kidney disease.